Rhodes Jason P Insider Trading
Get the latest insider transactions of Rhodes Jason P. Rhodes Jason P is President, CFO and Treasurer in Epizyme, Inc. ($EPZM) and Director in Generation Bio Co. ($GBIO) and Director in Replimune Group, Inc. ($REPL) and Director in Dyne Therapeutics, Inc. ($DYN). Discover the current value of Rhodes Jason P shares.
Address: C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE 02139MA
Rhodes Jason P is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
EPZM | Epizyme, Inc. | President, CFO and Treasurer | 138,000 | 1,662,900.00 |
REPL | Replimune Group, Inc. | Director | 946,000 | |
GBIO | Generation Bio Co. | Director | 77,329 | |
DYN | Dyne Therapeutics, Inc. | Director | 8,140,130 |
Insider Trading Transactions of Rhodes Jason P
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 26.07 | 63,353 | 1,651,613 | 77,329 |
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 26.61 | 10,771 | 286,616 | 66,558 |
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 25.09 | 35,791 | 897,996 | 30,767 |
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 25.53 | 7,354 | 187,748 | 23,413 |
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 26.40 | 10,539 | 278,230 | 12,874 |
Apr 14 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 26.78 | 12,874 | 344,766 | 0 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.48 | 37,970 | 1,081,386 | 229,807 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.48 | 37,970 | 1,081,386 | 229,807 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 29.19 | 1,894 | 55,286 | 227,913 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 29.19 | 1,894 | 55,286 | 227,913 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.47 | 40,359 | 1,149,021 | 187,554 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.47 | 40,359 | 1,149,021 | 187,554 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.90 | 3,191 | 92,220 | 184,363 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.90 | 3,191 | 92,220 | 184,363 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 27.57 | 41,549 | 1,145,506 | 142,814 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 27.57 | 41,549 | 1,145,506 | 142,814 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.35 | 2,132 | 60,442 | 140,682 |
Apr 09 2021 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Sell | 28.35 | 2,132 | 60,442 | 140,682 |
Apr 05 2021 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 31.58 | 16,500 | 521,070 | 16,500 |
Jan 28 2021 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 46.14 | 5,558 | 256,446 | 946,000 |
Dec 22 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 41.95 | 3,012 | 126,353 | 2,263,627 |
Dec 22 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 41.95 | 1,042 | 43,712 | 951,558 |
Dec 22 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 41.95 | 265 | 11,117 | 19,285 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.40 | 28,078 | 1,190,507 | 2,283,960 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.12 | 349 | 15,049 | 2,283,611 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.08 | 70 | 3,086 | 2,283,541 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.40 | 9,710 | 411,704 | 958,589 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.12 | 120 | 5,174 | 958,469 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.08 | 24 | 1,058 | 958,445 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.40 | 2,432 | 103,117 | 21,049 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.12 | 30 | 1,294 | 21,019 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.08 | 6 | 264 | 21,013 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.13 | 8,849 | 372,808 | 2,274,692 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.13 | 3,060 | 128,918 | 955,385 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.13 | 766 | 32,272 | 20,247 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.00 | 8,053 | 338,226 | 2,266,639 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.00 | 2,785 | 116,970 | 952,600 |
Dec 17 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.00 | 697 | 29,274 | 19,550 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.68 | 12,691 | 541,652 | 2,371,734 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.48 | 8,666 | 376,798 | 2,363,068 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.35 | 2,653 | 117,661 | 2,360,415 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.68 | 4,389 | 187,323 | 988,942 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.48 | 2,996 | 130,266 | 985,946 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.35 | 917 | 40,669 | 985,029 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.68 | 1,099 | 46,905 | 28,649 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.48 | 750 | 32,610 | 27,899 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.35 | 230 | 10,201 | 27,669 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.32 | 19,712 | 853,924 | 2,340,703 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.92 | 2,374 | 104,266 | 2,338,329 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.32 | 6,817 | 295,312 | 978,212 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.92 | 821 | 36,058 | 977,391 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.32 | 1,707 | 73,947 | 25,962 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.92 | 205 | 9,004 | 25,757 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.69 | 2,776 | 118,507 | 2,335,553 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.54 | 21,428 | 932,975 | 2,314,125 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.06 | 2,087 | 91,953 | 2,312,038 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.69 | 961 | 41,025 | 976,430 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.54 | 7,409 | 322,588 | 969,021 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.06 | 722 | 31,811 | 968,299 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 42.69 | 240 | 10,246 | 25,517 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 43.54 | 1,855 | 80,767 | 23,662 |
Dec 14 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Sell | 44.06 | 181 | 7,975 | 23,481 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Buy | 0.00 | 6,029,726 | 0 | 8,140,130 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Buy | 0.00 | 1,608,785 | 0 | 1,608,785 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Option Exercise | 0.00 | 20,000,000 | 0 | 0 |
Sep 23 2020 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Option Exercise | 0.00 | 5,336,179 | 0 | 0 |
Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Buy | 0.00 | 10,040,032 | 0 | 12,630,758 |
Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Option Exercise | 0.00 | 15,051,020 | 0 | 0 |
Jun 18 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Option Exercise | 0.00 | 2,683 | 0 | 0 |
Jun 15 2020 | GBIO | Generation Bio Co. | Rhodes Jason P | Director | Option Exercise | 19.00 | 52,000 | 988,000 | 52,000 |
Apr 02 2020 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 9.78 | 16,500 | 161,370 | 16,500 |
Nov 20 2019 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Buy | 13.61 | 1,100,000 | 14,971,000 | 1,100,000 |
Apr 03 2019 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 15.50 | 13,500 | 209,250 | 13,500 |
Jul 26 2018 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Buy | 0.00 | 3,439,839 | 0 | 3,439,839 |
Jul 26 2018 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Buy | 0.00 | 1,013,547 | 0 | 4,453,386 |
Jul 26 2018 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 0.00 | 3,439,839 | 0 | 0 |
Jul 26 2018 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 0.00 | 1,013,547 | 0 | 0 |
Jul 26 2018 | REPL | Replimune Group, Inc. | Rhodes Jason P | Director | Option Exercise | 15.00 | 13,500 | 202,500 | 13,500 |
Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 44,000 | 22,440 | 138,000 |
Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 44,000 | 22,440 | 149,459 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 6,000 | 21,240 | 88,000 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.60 | 36,000 | 21,600 | 124,000 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 33.37 | 24,028 | 801,771 | 99,972 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 33.89 | 5,972 | 202,392 | 94,000 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 6,000 | 21,240 | 188,833 |
Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.60 | 36,000 | 21,600 | 34,819 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 8,000 | 28,320 | 78,000 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.60 | 34,000 | 20,400 | 112,000 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 29.26 | 11,600 | 339,426 | 100,400 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 30.05 | 18,400 | 552,898 | 82,000 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 8,000 | 28,320 | 194,833 |
Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.60 | 34,000 | 20,400 | 70,819 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 6,000 | 21,240 | 64,000 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.60 | 4,000 | 2,400 | 68,000 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 32,000 | 16,320 | 100,000 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 32.52 | 23,554 | 765,903 | 76,446 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 33.55 | 6,446 | 216,258 | 70,000 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 6,000 | 21,240 | 202,833 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.60 | 4,000 | 2,400 | 104,819 |
Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 32,000 | 16,320 | 193,459 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 15,000 | 53,100 | 61,000 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 27,000 | 13,770 | 88,000 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 22.14 | 28,736 | 636,341 | 59,264 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 23.36 | 1,264 | 29,529 | 58,000 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 15,000 | 53,100 | 208,833 |
Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 27,000 | 13,770 | 225,459 |
May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 37,000 | 130,980 | 71,000 |
May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 5,000 | 2,550 | 76,000 |
May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 21.53 | 30,000 | 645,840 | 46,000 |
May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 37,000 | 130,980 | 223,833 |
May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 5,000 | 2,550 | 252,459 |
Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 35,000 | 17,850 | 59,000 |
Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 20.05 | 25,000 | 501,190 | 34,000 |
Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 35,000 | 17,850 | 257,459 |
Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 3.54 | 50,000 | 177,000 | 54,000 |
Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 20,000 | 10,200 | 74,000 |
Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 29.25 | 50,000 | 1,462,500 | 24,000 |
Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 3.54 | 50,000 | 177,000 | 260,833 |
Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 20,000 | 10,200 | 292,459 |
Jan 30 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 31.20 | 27,406 | 855,067 | 27,406 |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Buy | 0.51 | 14,000 | 7,140 | 14,000 |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Sell | 20.19 | 10,000 | 201,874 | 4,000 |
Jan 06 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 0.51 | 14,000 | 7,140 | 312,459 |
Jul 03 2013 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and Tr ... | Option Exercise | 29.95 | 50,000 | 1,497,500 | 50,000 |